Brief: Transcode Therapeutics Reports Positive Pre-Clinical Results In Metastatic Pancreatic Cancer With Its Lead Candidate, TTX-MC138

Transcode Therapeutics

12/12/2023 13:39

Dec 12 (Reuters) - Transcode Therapeutics Inc  RNAZ.O :
    * TRANSCODE THERAPEUTICS REPORTS POSITIVE PRE-CLINICAL
RESULTS IN
METASTATIC PANCREATIC CANCER WITH ITS LEAD CANDIDATE, TTX-MC138
    * TRANSCODE THERAPEUTICS INC - TTX-MC138 IS ALREADY BEING
TESTED
IN A PHASE 0 CLINICAL TRIAL WITH POTENTIAL TO ENTER PHASE I
CLINICAL TESTING IN 2024
    * TRANSCODE THERAPEUTICS INC - RESULTS UNDERSCORE EFFICACY
OF ITS
TTX PLATFORM FOR SYSTEMIC DELIVERY OF RNA-BASED THERAPEUTICS
INTO SOLID TUMORS

Source text for Eikon:  ID:nGNX8zCz8S 
Further company coverage:  RNAZ.O 

 ((Reuters.Briefs@thomsonreuters.com;))